Genomics

Dataset Information

Partially exhausted CD8+ T cells are associated with clinically beneficial response to Teplizumab in new onset type I diabetes


ABSTRACT: Partially exhausted CD8+ T cells are associated with clinically beneficial response to Teplizumab in new onset type I diabetes

PROVIDER: PRJNA338813 | ENA |

REPOSITORIES: ENA